Pharmaceuticals
News Releases
2018
December
October
Pharmaceuticals
Quick Navi-Reader for Diagnosis of Influenza to be Launched in Japan
Pharmaceuticals
Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health
Nutraceuticals
Launch of Nationwide Retail Distribution of "Barrier Beverage" BODYMAINTÉ Drink
September
August
Pharmaceuticals
Osaka University and Otsuka Pharmaceutical to Enter into an Executive LicensingAgreement on Novel "CAR-T Cell Therapy" for Multiple Myeloma
Corporate
Otsuka Pharmaceutical Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival
July
Pharmaceuticals
Otsuka and Lundbeck's Rxulti® (brexpiprazole) approved by the European Commission
Pharmaceuticals
Otsuka and Astex announce results of the phase 3 ASTRAL-1 study of guadecitabine (SGI-110) in treatment-naïve AML patients ineligible to receive intense induction chemotherapy
Nutraceuticals
Focus on Core Temperature as a Heat Disorder Countermeasure - New POCARI SWEAT ICE SLURRY "Cools from the Core" -
Pharmaceuticals
Otsuka Pharmaceutical to Acquire Visterra
Nutraceuticals
Launch of SOYJOY Manufacturing and Marketing in Indonesia
Nutraceuticals
Expansion of Overseas Marketing of POCARI SWEAT ION WATER July 2018 Marks Official Launch in Singapore
June
May
Nutraceuticals
Luscious peach flavor evokes a summery mood - New SOYJOY Crispy Peach -
Pharmaceuticals
Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Alzheimer's Disease
Pharmaceuticals
Otsuka Pharmaceutical Establishes Subsidiary in Singapore
Nutraceuticals
May 18 Launch of "Deliciously Illustrated SketchCook"Children's cooking illustrations transformed into vivid images and recipes in an entertaining dietary education app using state-of-the-art AI technology to teach nutrition
April
Pharmaceuticals
Otsuka's JYNARQUE™ (tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
REXULTI® Tablets, a New Antipsychotic Drug, Launched in Japan
Nutraceuticals
"Awake Refreshed, Revitalized" Kenja-no-Kaimin Sleep Rhythm Support, with a Foods with Function Claim, Now Available throughout Japan
Pharmaceuticals
Otsuka enters agreement with Takara Bio for co-development and sales rights in Japan to NY-ESO-1 siTCRTM and CD19 CAR gene therapies
March
Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Tottori Prefecture
Nutraceuticals
Otsuka Pharmaceutical Enters Into Comprehensive Regional Revitalization Partnership with Kyoto Prefecture
Pharmaceuticals
Otsuka's DELTYBA Approved in China for the Treatment of Multidrug-resistant Tuberculosis
Nutraceuticals
Introducing EQUELLE Gelée, a Flavorful and Convenient Supplement from the EQUELLE Brand - Supports women's beauty and health from the inside out -
Corporate
Otsuka Pharmaceutical Appoints Board Members and Statutory Auditors (PDF: 55.9 KB)
Nutraceuticals
New addition to SOYJOY line of soy snack bars- SOYJOY Crispy Banana -
February
Nutraceuticals
New EQUELLE Gelée Supports the Fundamentals of Women's Beauty and Health- New from the trusted EQUELLE brand, a flavorful, convenient equol supplement -
Corporate
Otsuka Pharmaceutical Certified for Two Years in a Row as Excellent Health and Productivity Management Enterprise
Nutraceuticals
Otsuka Pharmaceutical Serves as Official Partner for Tokyo Marathon 2018 - Helping Runners Give Their Best Performance for 12th Consecutive Year -
January
Pharmaceuticals
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid
Nutraceuticals
Otsuka Introduces Conditioning Drink Version of BODYMAINTÉ
Corporate
Otsuka Signs Statement of Support for Women's Empowerment Principles (PDF: 218.9 KB)
Pharmaceuticals
Otsuka Receives Approval in Japan for the Manufacture and Sale of New Antipsychotic Drug Rexulti® Tablets for Schizophrenia
Nutraceuticals